Asthma is a highly prevalent and increasingly common cause of limiting symptoms, and healthcare use across the world. It is usually readily treated with inexpensive regular medication. We work in Europe and LMIC to advance the understanding of asthma epidemiology, provide better information to patients, and to improve management through better use of existing treatments and trials of new technologies and medicines.